#Julphar

Julphar

UAE’s Julphar records Dhs1.9m in net profit for Q1 2022

Julphar recently announced its 2030 growth strategy

UAE’s Julphar to launch over 100 new products as part of its Strategy 2030

Julphar will expand its presence into new territories, including CIS countries, Turkey, Latin America and Africa, to create new revenue streams

UAE’s Julphar reports net profit of Dhs63.9m in 2021

The pharma company announced it had seen top line growth and a return to a profitable bottom line compared to the previous year

Abu Dhabi-based Yas Holding completes acquisition of Gulf Inject from Julphar

The acquisition comes as part of efforts to boost Yas Holding’s healthcare manufacturing and distribution ecosystem

Julphar Covid-19 Hayat Vaccine

UAE’s Julphar to start producing Covid-19 vaccines in April 2021

Julphar has inked a deal with G42 Medications Trading

Julphar announces 90% increase in revenues for Q2 2020

The company has announced a net loss of Dhs25.6m for Q2 2020

Ras Al Khaimah pharma company Julphar launches Dhs500m rights issue

The new capital is also expected to help it expand operations in key markets in the region

UAE pharma Julphar resumes exports to Saudi after suspension

The kingdom banned Julphar’s products in September 2018 for failing to meet regional standards

Julphar Signs Insulin Deal With US-Based Firm

Under the deal, EMD Millipore will sell recombinant human insulin manufactured by UAE-based pharmaceutical firm Julphar.

Julphar’s H1 Revenue Up 13.5%

The pharmaceutical company has seen a profit rise of 5.6 per cent for the first half of last year, with operating profit also up.